InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
14
T+90 hit rate
0%
T+90 mean return
-38.8%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Dupont Jakob, Vice-Président Exécutif, Responsable de la R&D. Insider active across 4 companies, notably Atara Biotherapeutics, Inc.. In total, 25 reports have been published. Breakdown: 0 buy · 14 sells. Total volume traded: €307k. History available since 18 May 2021. The latest transaction was disclosed on 26 March 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations25 total
38,741 shares0Common StockSEC:0000950170-24-038102:0
5,074 shares@ US$3.6274.1% of flowCommon StockSEC:0001567619-23-004537:0
141,328 shares0Common StockSEC:0001140361-23-010100:0
3,218 shares@ US$4.493.3% of flowCommon StockSEC:0001140361-22-042381:0
4,124 shares@ US$5.0344.9% of flowCommon StockSEC:0001140361-22-030300:0
3,873 shares@ US$5.3180.024% mcap5.3% of flowCommon StockSEC:0001140361-22-019981:0
78,506 shares0Common StockSEC:0001140361-22-007765:0
5,000 shares@ US$9.580.051% mcap11.4% of flowCommon StockSEC:0001567619-22-004499:0
5,000 shares@ US$9.580.032% mcap23.2% of flowCommon StockSEC:0001567619-22-000568
5,000 shares@ US$9.580.052% mcap11.5% of flowCommon StockSEC:0001567619-22-000568:0
5,000 shares@ US$9.5823.3% of flowCommon StockSEC:0001567619-21-021583
5,000 shares@ US$9.580.052% mcap11.5% of flowCommon StockSEC:0001567619-21-021583:0
2,199 shares@ US$17.116918.2% of flowCommon StockSEC:0001567619-21-020777
2,199 shares@ US$17.11690.041% mcap9.0% of flowCommon StockSEC:0001567619-21-020777:0
5,000 shares@ US$9.580.051% mcap11.3% of flowCommon StockSEC:0001567619-21-019331:0
5,000 shares@ US$9.5822.7% of flowCommon StockSEC:0001567619-21-019331
2,152 shares@ US$12.53212.7% of flowCommon StockSEC:0001567619-21-016145
2,152 shares@ US$12.5320.028% mcap6.3% of flowCommon StockSEC:0001567619-21-016145:0
5,184 shares@ US$14.5516.8% of flowCommon StockSEC:0001209191-21-034428
5,184 shares@ US$14.550.076% mcap16.8% of flowCommon StockSEC:0001209191-21-034428:0
2,500 sharesCommon StockSEC:0001140361-16-047651:0
2,500 sharesCommon StockSEC:0001140361-16-047651:1
2,092 sharesCommon StockSEC:0001140361-16-047340:0
69 sharesCommon StockSEC:0001140361-16-047340:1
1 sharesCommon StockSEC:0001140361-16-047340:2
25 of 25 declarations
About Dupont Jakob
Jakob Dupont is an executive at Atara Biotherapeutics, Inc.
